Advarra has announced the launch of Site IQ. The platform builds on Advarra's experience as the provider of practice management solutions for clinical research to deliver an integrated set of site and principal investigator insights to enable smarter site selection. The Site IQ platform provides customized data analysis to help sponsors and CROs make informed decisions in their investigative site selection and feasibility processes.
Advarra Site IQ delivers insights to drive study startup by supporting protocol planning and site selection processes. Site IQ informs intelligent site selection by leveraging comprehensive data across experience, capacity, quality, performance, and patient eligibility. Data is derived from Advarra's data as well as third-party partner data. As such, Site IQ reflects insights based on actual study and performance data, not estimates or self-reported information.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.